Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):44–50. doi: 10.1038/sj.bjc.6690319

Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours

W E Farrell 1, D J Simpson 1, J Bicknell 1, J L Magnay 1, E Kyrodimou 1,1, R V Thakker 2, R N Clayton 1
PMCID: PMC2363023  PMID: 10389976

Abstract

The majority of pituitary tumours are monoclonal in origin and arise sporadically or occasionally as part of multiple endocrine neoplasia type 1 (MEN1). Whilst a multi-step aetiology involving both oncogenes and tumour suppressor genes has been proposed for their development, the target(s) of these changes are less clearly defined. Both familial and sporadic pituitary tumours have been shown to harbour allelic deletion on 11q13, which is the location of the recently cloned MEN1 gene. We investigated 23 sporadic pituitary tumours previously shown to harbour allelic deletion on 11q13 with the marker PYGM centromeric and within 50 kb of the MEN1 locus. In addition, the use of intragenic polymorphisms in exon 9 and at D11S4946, and of telomeric loci at D11S4940 and D11S4936, revealed that five of 20 tumours had loss of heterozygosity (LOH) telomeric to the menin gene. However, the overall pattern of loss in informative cases was indicative of non-contiguous deletion that brackets the menin gene. Sequence analysis of all MEN1 coding exons and flanking intronic sequence, in tumours and matched patient leucocyte DNA, did not reveal mutation(s) in any of the 23 tumours studied. A benign polymorphism in exon 9 was encountered at the expected frequency, and in seven patients heterozygous for the polymorphism the tumour showed retention of both copies of the menin gene. Reverse transcription polymerase chain reaction analysis of ten evaluable tumours and four normal pituitaries revealed the presence of the menin transcript. Whilst these findings suggest that gene silencing is unlikely to be mechanistic in sporadic pituitary tumorigenesis, they do not exclude changes in the level or stability of the transcript or translation to mature protein. Our study would support and extend very recent reports of a limited role for mutations in the MEN1 gene in sporadic pituitary tumours. Alternatively, these findings may point to an, as yet, unidentified tumour suppressor gene in this region. © 1999 Cancer Research Campaign

Keywords: MEN1, loss of heterozygosity, pituitary tumours, menin transcript

Full Text

The Full Text of this article is available as a PDF (146.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal S. K., Kester M. B., Debelenko L. V., Heppner C., Emmert-Buck M. R., Skarulis M. C., Doppman J. L., Kim Y. S., Lubensky I. A., Zhuang Z. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997 Jul;6(7):1169–1175. doi: 10.1093/hmg/6.7.1169. [DOI] [PubMed] [Google Scholar]
  2. Alexander J. M., Biller B. M., Bikkal H., Zervas N. T., Arnold A., Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 1990 Jul;86(1):336–340. doi: 10.1172/JCI114705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bassett J. H., Forbes S. A., Pannett A. A., Lloyd S. E., Christie P. T., Wooding C., Harding B., Besser G. M., Edwards C. R., Monson J. P. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 1998 Feb;62(2):232–244. doi: 10.1086/301729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bates A. S., Farrell W. E., Bicknell E. J., McNicol A. M., Talbot A. J., Broome J. C., Perrett C. W., Thakker R. V., Clayton R. N. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab. 1997 Mar;82(3):818–824. doi: 10.1210/jcem.82.3.3799. [DOI] [PubMed] [Google Scholar]
  5. Boggild M. D., Jenkinson S., Pistorello M., Boscaro M., Scanarini M., McTernan P., Perrett C. W., Thakker R. V., Clayton R. N. Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab. 1994 Feb;78(2):387–392. doi: 10.1210/jcem.78.2.8106627. [DOI] [PubMed] [Google Scholar]
  6. Byström C., Larsson C., Blomberg C., Sandelin K., Falkmer U., Skogseid B., Oberg K., Werner S., Nordenskjöld M. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1968–1972. doi: 10.1073/pnas.87.5.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chandrasekharappa S. C., Guru S. C., Manickam P., Olufemi S. E., Collins F. S., Emmert-Buck M. R., Debelenko L. V., Zhuang Z., Lubensky I. A., Liotta L. A. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997 Apr 18;276(5311):404–407. doi: 10.1126/science.276.5311.404. [DOI] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Clementi E., Malgaretti N., Meldolesi J., Taramelli R. A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours. Oncogene. 1990 Jul;5(7):1059–1061. [PubMed] [Google Scholar]
  10. Cryns V. L., Alexander J. M., Klibanski A., Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab. 1993 Sep;77(3):644–646. doi: 10.1210/jcem.77.3.7690360. [DOI] [PubMed] [Google Scholar]
  11. Debelenko L. V., Zhuang Z., Emmert-Buck M. R., Chandrasekharappa S. C., Manickam P., Guru S. C., Marx S. J., Skarulis M. C., Spiegel A. M., Collins F. S. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res. 1997 Jun 1;57(11):2238–2243. [PubMed] [Google Scholar]
  12. Dong Q., Debelenko L. V., Chandrasekharappa S. C., Emmert-Buck M. R., Zhuang Z., Guru S. C., Manickam P., Skarulis M., Lubensky I. A., Liotta L. A. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1997 May;82(5):1416–1420. doi: 10.1210/jcem.82.5.3944. [DOI] [PubMed] [Google Scholar]
  13. Farrell W. E., Simpson D. J., Bicknell J. E., Talbot A. J., Bates A. S., Clayton R. N. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res. 1997 Jul 1;57(13):2703–2709. [PubMed] [Google Scholar]
  14. Friedman E., De Marco L., Gejman P. V., Norton J. A., Bale A. E., Aurbach G. D., Spiegel A. M., Marx S. J. Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res. 1992 Dec 15;52(24):6804–6809. [PubMed] [Google Scholar]
  15. Heppner C., Kester M. B., Agarwal S. K., Debelenko L. V., Emmert-Buck M. R., Guru S. C., Manickam P., Olufemi S. E., Skarulis M. C., Doppman J. L. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet. 1997 Aug;16(4):375–378. doi: 10.1038/ng0897-375. [DOI] [PubMed] [Google Scholar]
  16. Herman V., Fagin J., Gonsky R., Kovacs K., Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990 Dec;71(6):1427–1433. doi: 10.1210/jcem-71-6-1427. [DOI] [PubMed] [Google Scholar]
  17. Iida A., Blake K., Tunny T., Klemm S., Stowasser M., Hayward N., Gordon R., Nakamura Y., Imai T. Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors. Genes Chromosomes Cancer. 1995 Jan;12(1):73–75. doi: 10.1002/gcc.2870120114. [DOI] [PubMed] [Google Scholar]
  18. Jakobovitz O., Nass D., DeMarco L., Barbosa A. J., Simoni F. B., Rechavi G., Friedman E. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab. 1996 Sep;81(9):3164–3167. doi: 10.1210/jcem.81.9.8784062. [DOI] [PubMed] [Google Scholar]
  19. Landis C. A., Masters S. B., Spada A., Pace A. M., Bourne H. R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 1989 Aug 31;340(6236):692–696. doi: 10.1038/340692a0. [DOI] [PubMed] [Google Scholar]
  20. Lyons J., Landis C. A., Harsh G., Vallar L., Grünewald K., Feichtinger H., Duh Q. Y., Clark O. H., Kawasaki E., Bourne H. R. Two G protein oncogenes in human endocrine tumors. Science. 1990 Aug 10;249(4969):655–659. doi: 10.1126/science.2116665. [DOI] [PubMed] [Google Scholar]
  21. Manickam P., Guru S. C., Debelenko L. V., Agarwal S. K., Olufemi S. E., Weisemann J. M., Boguski M. S., Crabtree J. S., Wang Y., Roe B. A. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet. 1997 Nov;101(1):102–108. doi: 10.1007/s004390050595. [DOI] [PubMed] [Google Scholar]
  22. Melmed S. Pituitary neoplasia. Endocrinol Metab Clin North Am. 1994 Mar;23(1):81–92. [PubMed] [Google Scholar]
  23. Shimon I., Melmed S. Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab. 1997 Jun;82(6):1675–1681. doi: 10.1210/jcem.82.6.3987. [DOI] [PubMed] [Google Scholar]
  24. Simpson D. J., Bicknell J. E., McNicol A. M., Clayton R. N., Farrell W. E. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chromosomes Cancer. 1999 Apr;24(4):328–336. [PubMed] [Google Scholar]
  25. Thakker R. V., Pook M. A., Wooding C., Boscaro M., Scanarini M., Clayton R. N. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest. 1993 Jun;91(6):2815–2821. doi: 10.1172/JCI116524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Thakker R. V. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol (Oxf) 1993 Jan;38(1):1–14. doi: 10.1111/j.1365-2265.1993.tb00964.x. [DOI] [PubMed] [Google Scholar]
  27. Woloschak M., Yu A., Post K. D. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog. 1997 Aug;19(4):221–224. doi: 10.1002/(sici)1098-2744(199708)19:4<221::aid-mc1>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  28. Woloschak M., Yu A., Xiao J., Post K. D. Frequent loss of the P16INK4a gene product in human pituitary tumors. Cancer Res. 1996 Jun 1;56(11):2493–2496. [PubMed] [Google Scholar]
  29. Zhu J., Leon S. P., Beggs A. H., Busque L., Gilliland D. G., Black P. M. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab. 1994 Apr;78(4):922–927. doi: 10.1210/jcem.78.4.8157722. [DOI] [PubMed] [Google Scholar]
  30. Zhuang Z., Ezzat S. Z., Vortmeyer A. O., Weil R., Oldfield E. H., Park W. S., Pack S., Huang S., Agarwal S. K., Guru S. C. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 1997 Dec 15;57(24):5446–5451. [PubMed] [Google Scholar]
  31. Zhuang Z., Vortmeyer A. O., Pack S., Huang S., Pham T. A., Wang C., Park W. S., Agarwal S. K., Debelenko L. V., Kester M. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res. 1997 Nov 1;57(21):4682–4686. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES